Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease
Abstract
The safety and tolerability of high dosages of coenzyme Q10 were studied in 17 patients with Parkinson's disease (PD) in an open label study. The subjects received an escalating dosage of coenzyme Q10--1200, 1800, 2400, and 3000 mg/day with a stable dosage of vitamin E (alpha-tocopherol) 1200 IU/day. The plasma level of coenzyme Q10 was measured at each dosage. Thirteen of the subjects achieved the maximal dosage, and adverse events were typically considered to be unrelated to coenzyme Q10. The plasma level reached a plateau at the 2400 mg/day dosage and did not increase further at the 3000 mg/day dosage. Our data suggest that in future studies of coenzyme Q10 in PD, a dosage of 2400 mg/day (with vitamin E/alpha-tocopherol 1200 IU/day) is an appropriate highest dosage to be studied.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Plasma CoQ10 levels reached a plateau at the 2400 mg/day dosage and did not increase further at the 3000 mg/day dosage in PD, HD or ALS patients.
“However, plasma CoQ10 levels reached a plateau at the 2400 mg/day dosage and did not increase further at the 3000 mg/day dosage in PD, HD or ALS patients161, 162.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [161]
Cites
Effects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · see citing works
Self-citationStocker, R., Bowry, V. W., & Frei, B. B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1646 · Cited by 794 · see citing works
Mohr, D., Bowry, V. W., & Stocker, R. (1992) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(92)90237-p · Cited by 313 · see citing works
Biomedical and clinical aspects of coenzyme Q
Littarru, G. P. (1993) · Journal of Molecular Medicine · doi:10.1007/bf00184478 · Cited by 310 · see citing works
Lass, A., & Sohal, R. S. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1997.0606 · Cited by 162 · see citing works
Lass, A., & Sohal, R. S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.87 · Cited by 128 · see citing works
Bioavailability of four oral Coenzyme Q10 formulations in healthy volunteers
Weis, M., Mortensen, S. A., Rassing, M. R., Sonnergaard, J. M., Poulsen, G., & Rasmussen, S. N. (1994) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)90038-8 · Cited by 102 · see citing works
Kontush, A., Hübner, C., Finckh, B., Kohlschütter, A., & Beisiegel†, U. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00115-s · Cited by 75 · see citing works
Pharmacokinetic study of deuterium-labelled coenzyme Q10 in man.
Tomono, Y., Hasegawa, J., Seki, T., Motegi, K., & Morishita, N. (1986) · PubMed · Cited by 73 · see citing works
Interactions between ubiquinones and vitamins in membranes and cells
Constantinescu, A., Maguire, J. J., & Packer, L. (1994) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(94)90013-2 · Cited by 73 · see citing works
Human serum ubiquinol-10 levels and relationship to serum lipids.
Okamoto, T., Matsuya, T., Fukunaga, Y., Kishi, T., & Yamagami, T. (1989) · PubMed · Cited by 43 · see citing works
Oxidation of LDL and their subfractions: Kinetic aspects and CoQ10 content
Alleva, R., Tomasetti, M., Bompadre, S., & Littarru, G. P. (1997) · Molecular Aspects of Medicine · doi:10.1016/s0098-2997(97)00039-3 · Cited by 38 · see citing works
Treatments of Parkinson Disease
Shults, C. W. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1680 · Cited by 18 · see citing works
Self-citation(2019) · Current clinical neurology · doi:10.1007/978-3-319-97897-0 · Cited by 9 · see citing works
Flagged first, then by citations
2 of the 16 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Targeting Antioxidants to Mitochondria by Conjugation to Lipophilic Cations
Murphy, M. P., & Smith, R. A. J. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105110 · Cited by 1,173 · see citing works
Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target
Barber, S. C., & Shaw, P. J. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.018 · Cited by 617 · see citing works
Coenzyme Q10: Absorption, tissue uptake, metabolism and pharmacokinetics
Bhagavan, H. N., & Chopra, R. K. (2006) · Free Radical Research · doi:10.1080/10715760600617843 · Cited by 550 · see citing works
Mitochondrial Diseases of the Brain
Chaturvedi, R. K., & Beal, M. F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.018 · Cited by 416 · see citing works
A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease
The Parkinson Study Group QE3 Investigators, Beal, M. F., Oakes, D., Shoulson, I., Henchcliffe, C., Galpern, W. R., Haas, R., Juncos, J. L., Nutt, J. G., Voss, T., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.131 · Cited by 410 · see citing works
Self-citationA modern approach to the treatment of mitochondrial disease
The Mitochondrial Medicine Society, Parikh, S., Saneto, R. P., Falk, M. J., Anselm, I. A., Cohen, B. H., & Haas, R. (2009) · Current Treatment Options in Neurology · doi:10.1007/s11940-009-0046-0 · Cited by 349 · see citing works
Mitochondrial Approaches for Neuroprotection
Chaturvedi, R. K., & Beal, M. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.027 · Cited by 294 · see citing works
Self-citationEnergy metabolism in ALS: an underappreciated opportunity?
Vandoorne, T., Bock, K. D., & Bosch, L. V. D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1835-x · Cited by 260 · see citing works
Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations
Bhagavan, H. N., & Chopra, R. K. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.03.003 · Cited by 243 · see citing works
Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges
Arenas‐Jal, M., Suñé‐Negre, J. M., & García‐Montoya, E. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12539 · Cited by 239 · see citing works
Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III
Kaufmann, P., Thompson, J. L. P., Levy, G., Buchsbaum, R., Shefner, J. M., Krivickas, L. S., Katz, J., Rollins, Y. D., Barohn, R. J., Jackson, C. E., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21743 · Cited by 236 · see citing works
α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease
Halliday, G. M., Ophof, A., Broe, M., Jensen, P. H., Kettle, E., Fedorow, H., Cartwright, M., Carew‐Jones, F., Shepherd, C. E., & Double, K. L. (2005) · Brain · doi:10.1093/brain/awh584 · Cited by 219 · see citing works
A randomized clinical trial of coenzyme Q 10 and GPI-1485 in early Parkinson disease
The NINDS NET-PD Investigators (2007) · Neurology · doi:10.1212/01.wnl.0000250355.28474.8e · Cited by 219 · see citing works
Targeting the Redox Balance in Inflammatory Skin Conditions
Wagener, F. A. D. T. G., Carels, C. E. L., & Lundvig, D. M. S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059126 · Cited by 219 · see citing works
Storch, A. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.nct60005 · Cited by 205 · see citing works
The emerging role of nutrition in Parkinson's disease
Seidl, S. E., Santiago, J. A., Bilyk, H. T., & Potashkin, J. A. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00036 · Cited by 209 · see citing works
Coenzyme Q10 Deficiency and Response to Supplementation in Pediatric and Adolescent Migraine
Hershey, A. D., Powers, S. W., Vockell, A.-L. B., LeCates, S. L., Ellinor, P. L., Segers, A. M., Burdine, D., Manning, P., & Kabbouche, M. A. (2007) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2007.00652.x · Cited by 197 · see citing works
Coenzyme Q10 effects in neurodegenerative disease
Henchcliffe, C. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s5212 · Cited by 188 · see citing works
Safety assessment of coenzyme Q 10 (CoQ 10 )
Hidaka, T., Fujii, K., Funahashi, I., Fukutomi, N., & Hosoe, K. (2008) · BioFactors · doi:10.1002/biof.5520320124 · Cited by 187 · see citing works
Clinical applications of coenzyme Q₁₀
Garrido-Maraver, J. (2014) · Frontiers in Bioscience · doi:10.2741/4231 · Cited by 178 · see citing works
Evidence of Oxidant Damage in Huntington's Disease: Translational Strategies Using Antioxidants
Stack, E. C., Matson, W. R., & Ferrante, R. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.008 · Cited by 167 · see citing works
Tarnopolsky, M. A. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.05.001 · Cited by 158 · see citing works
Tolerance of high‐dose (3,000 mg/day) coenzyme Q10 in ALS
Ferrante, K. L., Shefner, J., Zhang, H., Betensky, R., O'Brien, M., Yu, H., Fantasia, M., Taft, J., Beal, M. F., Traynor, B., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187070.35365.d7 · Cited by 154 · see citing works
Garrido‐Maraver, J., Cordero, M. D., Oropesa-Ávila, M., Fernández-Vega, A., de la Mata, M., Pavón, A. D., de Miguel, M., Calero, C. P., Paz, M. V., Cotán, D., et al. (2014) · Molecular Syndromology · doi:10.1159/000360101 · Cited by 154 · see citing works
Faust, K., Gehrke, S., Yang, Y., Yang, L., Beal, M. F., & Lu, B. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-109 · Cited by 151 · see citing works
Coenzyme Q10 and Heart Failure
Sharma, A., Fonarow, G. C., Butler, J., Ezekowitz, J. A., & Felker, G. M. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002639 · Cited by 150 · see citing works
Nucci, C., Tartaglione, R., Cerulli, A., Mancino, R., Spanò, A., Cavaliere, F., Rombolà, L., Bagetta, G., Corasaniti, M. T., & Morrone, L. A. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82022-8 · Cited by 143 · see citing works
Mitochondrial mechanisms of estrogen neuroprotection
Simpkins, J. W., & Dykens, J. A. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.04.007 · Cited by 145 · see citing works
The Promise of Neuroprotective Agents in Parkinson?s Disease
Seidl, S. E., & Potashkin, J. A. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00068 · Cited by 141 · see citing works
Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 139 · see citing works
A randomized trial of coenzyme Q 10 in mitochondrial disorders
Glover, E. I., Martin, J. C., Maher, A. C., Thornhill, R. E., Moran, G. R., & Tarnopolsky, M. A. (2010) · Muscle & Nerve · doi:10.1002/mus.21758 · Cited by 137 · see citing works
Mitochondrial targeting of quinones: Therapeutic implications
Cochemé, H. M., Kelso, G. F., James, A. M., Ross, M. F., Trnka, J., Mahendiran, T., Asin-Cayuela, J., Blaikie, F. H., Manas, A. B., Porteous, C. M., et al. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.02.007 · Cited by 138 · see citing works
Therapeutic use of coenzyme Q 10 and coenzyme Q 10 -related compounds and formulations
Villalba, J. M., Parrado‐Fernández, C., González, M. S., & Alcain, F. J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543781003727495 · Cited by 134 · see citing works
Hosoe, K., Kitano, M., Kishida, H., Kubo, H., Fujii, K., & Kitahara, M. (2006) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2006.07.001 · Cited by 133 · see citing works
Tsai, K., Huang, Y., Kao, C.-L., Yang, D., Lee, H., Chou, H., Chen, Y., Chiou, G., Chen, L.-H., Yang, Y.-P., et al. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.01.011 · Cited by 132 · see citing works
Hickey, M. A., Zhu, C., Medvedeva, V. P., Lerner, R. P., Patassini, S., Franich, N. R., Maiti, P., Frautschy, S. A., Zeitlin, S. O., Levine, M. S., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-12 · Cited by 130 · see citing works
Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice
Smith, K. M., Matson, S., Matson, W. R., Cormier, K., Del Signore, S. J., Hagerty, S. W., Stack, E. C., Ryu, H., & Ferrante, R. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.03.004 · Cited by 127 · see citing works
The uptake and distribution of coenzyme Q(10)
Miles, M. V. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.02.012 · Cited by 126 · see citing works
Slater, S. K., Nelson, T. D., Kabbouche, M. A., LeCates, S. L., Horn, P. S., Segers, A. M., Manning, P., Powers, S. W., & Hershey, A. D. (2011) · Cephalalgia · doi:10.1177/0333102411406755 · Cited by 125 · see citing works
Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation
Potgieter, M., Pretorius, E., & Pepper, M. S. (2013) · Nutrition Reviews · doi:10.1111/nure.12011 · Cited by 124 · see citing works
Members, E. W. E., Terron, A., Bal-Price, A., Paini, A., Monnet-Tschudi, F., Bennekou, S. H., Leist, M., & Schildknecht, S. (2018) · Archives of Toxicology · doi:10.1007/s00204-017-2133-4 · Cited by 124 · see citing works
Kerr, D. S. (2009) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2009.11.005 · Cited by 121 · see citing works
Bolaños, J. P., Moro, M. Á., Lizasoaín, I., & Almeida, Á. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.009 · Cited by 119 · see citing works
Somayajulu‐Nitu, M., Sandhu, J. K., Cohen, J. S., Sikorska, M., Sridhar, T., Matei, A., Borowy‐Borowski, H., & Pandey, S. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-88 · Cited by 117 · see citing works
Risk assessment for coenzyme Q10 (Ubiquinone)
Hathcock, J. N., & Shao, A. (2006) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2006.05.006 · Cited by 114 · see citing works
Coenzyme Q10 deficiency in patients with Parkinson's disease
Mischley, L. K., Allen, J., & Bradley, R. D. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.03.023 · Cited by 111 · see citing works
Tsuneki, H., Sekizaki, N., Suzuki, T., Kobayashi, S., Wada, T., Okamoto, T., Kimura, I., & Sasaoka, T. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.006 · Cited by 104 · see citing works
Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease
Beal, M. F. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70812-0 · Cited by 103 · see citing works
Kidd, P. M. (2005) · PubMed · Cited by 104 · see citing works
Öz, G., Hutter, D., Tkáč, I., Clark, H. B., Gross, M., Jiang, H., Eberly, L. E., Bushara, K., & Gomez, C. M. (2010) · Movement Disorders · doi:10.1002/mds.23067 · Cited by 101 · see citing works
Coenzyme Q10:A Review of Its Promise as a Neuroprotectant
Young, A. J., Johnson, S., Steffens, D. C., & Doraiswamy, P. M. (2007) · CNS Spectrums · doi:10.1017/s1092852900020538 · Cited by 97 · see citing works
Review of clinical trials for mitochondrial disorders: 1997-2012
Kerr, D. S. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0176-7 · Cited by 96 · see citing works
Morris, G., Anderson, G., Berk, M., & Maes, M. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8477-8 · Cited by 96 · see citing works
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease
Haas, R. H. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.03.008 · Cited by 92 · see citing works
Tsai, K., Chen, L., Chiou, S., Chiou, G., Chen, Y., Chou, H., Chen, L., Chen, H., Chiu, T., Tsai, C., et al. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100147 · Cited by 93 · see citing works
Co‐enzyme Q10 and idebenone use in Friedreich's ataxia
Parkinson, M. H., Schulz, J. B., & Giunti, P. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12322 · Cited by 92 · see citing works
Clinical aspects of coenzyme Q10: an update
Littarru, G. P., & Tiano, L. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000171123.60665.16 · Cited by 92 · see citing works
Safety and tolerability of high‐dosage coenzyme Q10 in Huntington's disease and healthy subjects
The Huntington Study Group Pre2CARE Investigators (2010) · Movement Disorders · doi:10.1002/mds.22408 · Cited by 91 · see citing works
Coenzyme Q10: is there a clinical role and a case for measurement?
Molyneux, S. L., Young, J. M., Florkowski, C. M., Lever, M., & George, P. M. (2008) · PubMed Central · Cited by 87 · see citing works
Strategies for oral delivery and mitochondrial targeting of CoQ10
Zaki, N. M. (2014) · Drug Delivery · doi:10.3109/10717544.2014.993747 · Cited by 85 · see citing works
Antioxidants, Supplements, and Parkinson's Disease
Weber, C. A., & Ernst, M. E. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g551 · Cited by 85 · see citing works
Neurochemical abnormalities in premanifest and early spinocerebellar ataxias
Joers, J. M., Deelchand, D. K., Lyu, T., Emir, U. E., Hutter, D., Gomez, C. M., Bushara, K. O., Eberly, L. E., & Öz, G. (2018) · Annals of Neurology · doi:10.1002/ana.25212 · Cited by 84 · see citing works
Coenzyme Q10: Clinical Applications beyond Cardiovascular Diseases
Testai, L., Martelli, A., Flori, L., Cicero, A. F. G., & Colletti, A. (2021) · Nutrients · doi:10.3390/nu13051697 · Cited by 82 · see citing works
Coenzyme Q10 and Immune Function: An Overview
Mantle, D., Heaton, R. A., & Hargreaves, I. P. (2021) · Antioxidants · doi:10.3390/antiox10050759 · Cited by 84 · see citing works
Treating neurodegeneration by modifying mitochondria: potential solutions to a “complex” problem
Swerdlow, R. H. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1676 · Cited by 81 · see citing works
Mitochondrial medicine for neurodegenerative diseases
Du, H., & Yan, S. S. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.01.004 · Cited by 81 · see citing works
Coenzyme Q treatment of neurodegenerative diseases of aging
Galpern, W. R., & Cudkowicz, M. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.01.004 · Cited by 78 · see citing works
Suksomboon, N., Poolsup, N., & Juanak, N. (2015) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12280 · Cited by 77 · see citing works
Abdin, A. A., & Hamouda, H. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.033 · Cited by 77 · see citing works
Common Mechanisms Underlying α-Synuclein-Induced Mitochondrial Dysfunction in Parkinson’s Disease
Sohrabi, T., Mirzaei-Behbahani, B., Zadali, R., Pirhaghi, M., Morozova‐Roche, L. A., & Meratan, A. A. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.167992 · Cited by 78 · see citing works
Therapeutic role of coenzyme Q10 in Parkinson's disease
Shults, C. W. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.02.002 · Cited by 76 · see citing works
Self-citationRusso, R., Cavaliere, F., Rombolà, L., Gliozzi, M., Cerulli, A., Nucci, C., Fazzi, E. M., Bagetta, G., Corasaniti, M. T., & Morrone, L. A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)01139-4 · Cited by 76 · see citing works
Nierenberg, A. A., Kansky, C., Brennan, B. P., Shelton, R. C., Perlis, R. H., & Iosifescu, D. V. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449303 · Cited by 76 · see citing works
Lesser, G. J., Case, D., Stark, N. N., Williford, S., Giguere, J. K., Garino, L. A., Naughton, M. J., Vitolins, M. Z., Lively, M. O., & Shaw, E. G. (2012) · The Journal of Supportive Oncology · doi:10.1016/j.suponc.2012.03.003 · Cited by 75 · see citing works
Microencapsulation of ubiquinone-10 in carbohydrate matrices for improved stability
Bule, M. V., Singhal, R. S., & Kennedy, J. F. (2010) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2010.07.012 · Cited by 75 · see citing works
Menalled, L., Patry, M., Ragland, N., Lowden, P. A. S., Goodman, J., Minnich, J., Zahasky, B., Park, L., Leeds, J. M., Howland, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009793 · Cited by 70 · see citing works
Clinical neuroprotection in Parkinson's disease — Still waiting for the breakthrough
Löhle, M., & Reichmann, H. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.025 · Cited by 69 · see citing works
Current state of coenzyme Q10 production and its applications
Jeya, M., Moon, H.-J., Lee, J.-L., Kim, I., & Lee, J.-K. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2380-2 · Cited by 66 · see citing works
Naderi, J., Somayajulu‐Nitu, M., Mukerji, A., Sharda, P. R., Sikorska, M., Borowy‐Borowski, H., Antonsson, B. E., & Pandey, S. (2006) · APOPTOSIS · doi:10.1007/s10495-006-8417-4 · Cited by 66 · see citing works
Yan, N., Liu, Y., Gong, D., Du, Y., Zhang, H., & Zhang, Z. (2015) · Phytochemistry Reviews · doi:10.1007/s11101-015-9393-5 · Cited by 66 · see citing works
CoQ10 in progressive supranuclear palsy
Apetauerova, D., Scala, S., Hamill, R. W., Simon, D. K., Pathak, S., Ruthazer, R., Standaert, D. G., & Yacoubian, T. A. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000266 · Cited by 66 · see citing works
Liang, Q., Smith, A. D., Pan, S., Tyurin, V. A., Kagan, V. E., Hastings, T. G., & Schor, N. F. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.011 · Cited by 65 · see citing works
CoQ10Function and Role in Heart Failure and Ischemic Heart Disease
Ayer, A., Macdonald, P. S., & Stocker, R. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034258 · Cited by 64 · see citing works
Park, H. W., Park, C. G., Park, M. J., Lee, S. H., Park, H. R., Lim, J., Paek, S. H., & Choy, Y. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-66493-w · Cited by 67 · see citing works
Clinical trials of coenzyme Q10 in neurological disorders
Shults, C. W., & Haas, R. (2005) · BioFactors · doi:10.1002/biof.5520250113 · Cited by 62 · see citing works
Self-citationPotential role of coenzyme Q10 in health and disease conditions
Rodick, T. C., Seibels, D. R., Babu, J. R., Huggins, K. W., Ren, G., & Mathews, S. T. (2018) · Nutrition and Dietary Supplements · doi:10.2147/nds.s112119 · Cited by 58 · see citing works
Tragni, V., Primiano, G., Tummolo, A., Beltrame, L. C., Piana, G. L., Sgobba, M. N., Cavalluzzi, M. M., Paterno, G., Gorgoglione, R., Volpicella, M., et al. (2022) · Molecules · doi:10.3390/molecules27113494 · Cited by 55 · see citing works
Sharma, N., Upadhayay, S., Shandilya, A., Sahu, R., Singh, A., Rajkhowa, B., & Mehan, S. (2021) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100051 · Cited by 54 · see citing works
The Podocyte Power-Plant Disaster and Its Contribution to Glomerulopathy
Müller‐Deile, J., & Schiffer, M. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00209 · Cited by 53 · see citing works
Solanesol: Added value from Solanaceous waste
Taylor, M. A., & Fraser, P. D. (2011) · Phytochemistry · doi:10.1016/j.phytochem.2011.03.015 · Cited by 51 · see citing works
Heidari, R. (2019) · Toxicology · doi:10.1016/j.tox.2019.05.002 · Cited by 50 · see citing works
Antiapoptotic Drugs: A Therapautic Strategy for the Prevention of Neurodegenerative Diseases
Sureda, F. X., Junyent, F., Verdaguer, E., Auladell, C., Pelegrı́, C., Vilaplana, J., Folch, J., Canudas, A. M., Zárate, C. B., Pallàs, M., et al. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049732 · Cited by 49 · see citing works
Young, J. M., Florkowski, C. M., Molyneux, S. L., McEwan, R. G., Frampton, C. M., Nicholls, M. G., Scott, R. S., & George, P. M. (2012) · American Journal of Hypertension · doi:10.1038/ajh.2011.209 · Cited by 59 · see citing works
Mitochondrial dysfunction in mouse trisomy 16 brain
Bambrick, L. L., & Fiskum, G. M. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.045 · Cited by 48 · see citing works
Prolonged Intake of Coenzyme Q10 Impairs Cognitive Functions in Mice
Sumien, N., Heinrich, K. R., Shetty, R. A., Sohal, R. S., & Forster, M. J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.110437 · Cited by 46 · see citing works
Fukuda, S., Nojima, J., Kajimoto, O., Yamaguti, K., Nakatomi, Y., Kuratsune, H., & Watanabe, Y. (2016) · BioFactors · doi:10.1002/biof.1293 · Cited by 45 · see citing works
Mitsui, J., Koguchi, K., Momose, T., Takahashi, M., Matsukawa, T., Yasuda, T., Tokushige, S., Ishiura, H., Goto, J., Nakazaki, S., et al. (2017) · The Cerebellum · doi:10.1007/s12311-017-0846-9 · Cited by 45 · see citing works
Biological Variation of Coenzyme Q10
Molyneux, S. L., Florkowski, C. M., Lever, M., & George, P. M. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.043653 · Cited by 43 · see citing works
Prasuhn, J., Brüggemann, N., Heßler, N., Berg, D., Gasser, T., Brockmann, K., Olbrich, D., Ziegler, A., König, I. R., Klein, C., et al. (2019) · Neurological Research and Practice · doi:10.1186/s42466-019-0033-1 · Cited by 42 · see citing works
Clinical trials for neuroprotection in Parkinson??s disease: overcoming angst and futility?
Hung, A. Y., & Schwarzschild, M. A. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32826388d6 · Cited by 42 · see citing works
- Authors
- Shults, C. W., Flint Beal, M., Song, D., & Fontaine, D.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Shults, Clifford W.
- ORCID
- Song, David
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 188
- Issue
- 2
- Pages
- 491-494
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W1990908870
- Cited by
- 223
- References
- 16
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 1 · 2023: 8 · 2022: 8 · 2021: 10 · 2020: 8 · 2019: 6 · 2018: 6 · 2017: 7 · 2016: 9 · 2015: 7 · 2014: 13 · 2013: 13 · 2012: 13
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- coenzyme Q10, Parkinson's disease, high-dose supplementation, vitamin E, alpha-tocopherol, safety and tolerability, dose escalation, adverse events
- MeSH terms
- Calcium, Coenzymes, Cognition, Dose-Response Relationship, Drug, Drug Therapy, Combination, Dyspepsia, Female, Humans, Male, Middle Aged, Motor Activity, Parkinson Disease, Pilot Projects, Safety, Time Factors, Ubiquinone, Vitamin E
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
